Current Radiopharmaceuticals

Papers
(The H4-Index of Current Radiopharmaceuticals is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
FDG PET/CT in the Staging of Lung Cancer39
Lung Cancer and Radiological Imaging35
Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial23
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)17
PET/CT and the Response to Immunotherapy in Lung Cancer17
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art16
Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.14
Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-4714
Artificial Neural Networks in Cardiovascular Diseases and its Potential for Clinical Application in Molecular Imaging13
IAEA Activities on 67Cu, 186Re, 47Sc Theranostic Radionuclides and Radiopharmaceuticals12
Alternative and New Radiopharmaceutical Agents for Lung Cancer12
0.028864145278931